Probiotics for Childhood Functional Gastrointestinal Disorders: Do We Know What We Advise?

P. D. Browne, A. C. de Groen, E. Claassen, M. A. Benninga

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Limited information is available on clinicians’ advising practices and perceived familiarity of probiotics in the management of childhood functional abdominal pain disorders (FAPDs) and functional defecation disorders (FDD). This study aimed to investigate pediatricians’ and general practitioners’ (GPs) advising practices and perceived familiarity of probiotics in the management of FAPDs and FDD. A cross-sectional survey was administered to Dutch pediatricians and GPs, including 27 questions about perceived familiarity of probiotics, followed by questions related to advising practices and reasons for advising or not advising probiotics. The responses of 319 pediatricians and 67 GPs were included. Significantly more pediatricians indicated to be familiar with probiotics compared to GPs (71% vs. 48% respectively, p < 0.001). Significantly more pediatricians advised probiotics compared to GPs for FAPDs (54% vs. 25%, respectively, p < 0.001) and for FDD (17% vs. 7%, respectively, p < 0.05). Primary reason to advise probiotics was patient request; main reason not to advise probiotics was personal lack of knowledge regarding probiotic use. Conclusions: Increased familiarity and appropriate advising of probiotics in treatment of childhood FAPDs and FDD among pediatricians and GPs is required. Improved familiarity of probiotics is important to provide appropriate information about probiotic use to children and caregivers and may facilitate shared decision-making.

Original languageEnglish
Article number100160
Pages (from-to)1-7
Number of pages7
JournalPharmaNutrition
Volume10
Early online date25 Jun 2019
DOIs
Publication statusPublished - 1 Dec 2019

Fingerprint

Gastrointestinal Diseases
Probiotics
digestive system diseases
childhood
probiotics
pediatricians
general practitioners
General Practitioners
Somatoform Disorders
Defecation
defecation
Abdominal Pain
pain
health care workers
cross-sectional studies
Caregivers
Pediatricians
decision making
Decision Making
Cross-Sectional Studies

Keywords

  • Children
  • Functional gastro-intestinal disorders
  • Patient consultation
  • Probiotics

Cite this

@article{eb47bc256eb44eedac26bdf75f563616,
title = "Probiotics for Childhood Functional Gastrointestinal Disorders: Do We Know What We Advise?",
abstract = "Limited information is available on clinicians’ advising practices and perceived familiarity of probiotics in the management of childhood functional abdominal pain disorders (FAPDs) and functional defecation disorders (FDD). This study aimed to investigate pediatricians’ and general practitioners’ (GPs) advising practices and perceived familiarity of probiotics in the management of FAPDs and FDD. A cross-sectional survey was administered to Dutch pediatricians and GPs, including 27 questions about perceived familiarity of probiotics, followed by questions related to advising practices and reasons for advising or not advising probiotics. The responses of 319 pediatricians and 67 GPs were included. Significantly more pediatricians indicated to be familiar with probiotics compared to GPs (71{\%} vs. 48{\%} respectively, p < 0.001). Significantly more pediatricians advised probiotics compared to GPs for FAPDs (54{\%} vs. 25{\%}, respectively, p < 0.001) and for FDD (17{\%} vs. 7{\%}, respectively, p < 0.05). Primary reason to advise probiotics was patient request; main reason not to advise probiotics was personal lack of knowledge regarding probiotic use. Conclusions: Increased familiarity and appropriate advising of probiotics in treatment of childhood FAPDs and FDD among pediatricians and GPs is required. Improved familiarity of probiotics is important to provide appropriate information about probiotic use to children and caregivers and may facilitate shared decision-making.",
keywords = "Children, Functional gastro-intestinal disorders, Patient consultation, Probiotics",
author = "Browne, {P. D.} and {de Groen}, {A. C.} and E. Claassen and Benninga, {M. A.}",
year = "2019",
month = "12",
day = "1",
doi = "10.1016/j.phanu.2019.100160",
language = "English",
volume = "10",
pages = "1--7",
journal = "PharmaNutrition",
issn = "2213-4344",
publisher = "Elsevier BV",

}

Probiotics for Childhood Functional Gastrointestinal Disorders : Do We Know What We Advise? / Browne, P. D.; de Groen, A. C.; Claassen, E.; Benninga, M. A.

In: PharmaNutrition, Vol. 10, 100160, 01.12.2019, p. 1-7.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Probiotics for Childhood Functional Gastrointestinal Disorders

T2 - Do We Know What We Advise?

AU - Browne, P. D.

AU - de Groen, A. C.

AU - Claassen, E.

AU - Benninga, M. A.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Limited information is available on clinicians’ advising practices and perceived familiarity of probiotics in the management of childhood functional abdominal pain disorders (FAPDs) and functional defecation disorders (FDD). This study aimed to investigate pediatricians’ and general practitioners’ (GPs) advising practices and perceived familiarity of probiotics in the management of FAPDs and FDD. A cross-sectional survey was administered to Dutch pediatricians and GPs, including 27 questions about perceived familiarity of probiotics, followed by questions related to advising practices and reasons for advising or not advising probiotics. The responses of 319 pediatricians and 67 GPs were included. Significantly more pediatricians indicated to be familiar with probiotics compared to GPs (71% vs. 48% respectively, p < 0.001). Significantly more pediatricians advised probiotics compared to GPs for FAPDs (54% vs. 25%, respectively, p < 0.001) and for FDD (17% vs. 7%, respectively, p < 0.05). Primary reason to advise probiotics was patient request; main reason not to advise probiotics was personal lack of knowledge regarding probiotic use. Conclusions: Increased familiarity and appropriate advising of probiotics in treatment of childhood FAPDs and FDD among pediatricians and GPs is required. Improved familiarity of probiotics is important to provide appropriate information about probiotic use to children and caregivers and may facilitate shared decision-making.

AB - Limited information is available on clinicians’ advising practices and perceived familiarity of probiotics in the management of childhood functional abdominal pain disorders (FAPDs) and functional defecation disorders (FDD). This study aimed to investigate pediatricians’ and general practitioners’ (GPs) advising practices and perceived familiarity of probiotics in the management of FAPDs and FDD. A cross-sectional survey was administered to Dutch pediatricians and GPs, including 27 questions about perceived familiarity of probiotics, followed by questions related to advising practices and reasons for advising or not advising probiotics. The responses of 319 pediatricians and 67 GPs were included. Significantly more pediatricians indicated to be familiar with probiotics compared to GPs (71% vs. 48% respectively, p < 0.001). Significantly more pediatricians advised probiotics compared to GPs for FAPDs (54% vs. 25%, respectively, p < 0.001) and for FDD (17% vs. 7%, respectively, p < 0.05). Primary reason to advise probiotics was patient request; main reason not to advise probiotics was personal lack of knowledge regarding probiotic use. Conclusions: Increased familiarity and appropriate advising of probiotics in treatment of childhood FAPDs and FDD among pediatricians and GPs is required. Improved familiarity of probiotics is important to provide appropriate information about probiotic use to children and caregivers and may facilitate shared decision-making.

KW - Children

KW - Functional gastro-intestinal disorders

KW - Patient consultation

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=85068566603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068566603&partnerID=8YFLogxK

U2 - 10.1016/j.phanu.2019.100160

DO - 10.1016/j.phanu.2019.100160

M3 - Article

VL - 10

SP - 1

EP - 7

JO - PharmaNutrition

JF - PharmaNutrition

SN - 2213-4344

M1 - 100160

ER -